Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1818
+0.0057 (3.24%)
At close: Aug 11, 2026, 4:00 PM EDT
0.1823
+0.0005 (0.28%)
After-hours: Aug 11, 2026, 7:23 PM EDT
GOSS's stock price has decreased by -89.67% in the past year and price targets may not have had time to catch up.
Gossamer Bio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $1 | Hold | Maintains | $1 | +450.06% | Jul 29, 2026 |
| Barclays | Barclays | Sell Maintains $0.28 | Sell | Maintains | $0.28 | +54.02% | Jul 28, 2026 |
| Leerink Partners | Leerink Partners | Buy Upgrades $1 | Buy | Upgrades | $1 | +450.06% | Jul 27, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $2 | Buy | Reiterates | $2 | +1,000.11% | Jul 27, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 19, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Mar 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 | Buy | Maintains | $15 | +8,150.83% | Mar 18, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Downgrades $8 → $0.5 | Hold | Downgrades | $8 → $0.5 | +175.03% | Feb 25, 2026 |